Takenaka Tomofumi, Nishida Takeo, Takagaki Masatoshi, Okita Yoshiko, Kijima Noriyuki, Hirayama Ryuichi, Matsui Yuichi, Yamada Shuhei, Fukuda Tatsumaru, Nakagawa Ryota, Matsumura Takaki, Arisawa Atsuko, Takahashi Hiroto, Nakamura Hajime, Kagawa Naoki, Kishima Haruhiko
Department of Neurosurgery, Osaka Neurological Institute, Toyonaka, Japan.
Department of Neurosurgery, The University of Osaka Graduate School of Medicine, Suita, Osaka, Japane.
Interv Neuroradiol. 2025 May 5:15910199251332457. doi: 10.1177/15910199251332457.
Background and purposeMeningiomas often contain a pial supply, and devascularization through preoperative transarterial embolization (TAE) is useful. However, the efficacy indicators of TAE for meningiomas with pial feeders remain unclear owing to their challenging quantification. Therefore, we propose a practical and quantitative intratumoral cerebral blood volume (CBV) from the pial supply, called pial-nCBV. This study aimed to identify the efficacy indicators of TAE against meningiomas in pial feeders using pial-nCBV.Materials and methodsBetween 2015 and 2021, 25 patients who underwent preoperative TAE and perfusion magnetic resonance imaging (MRI) for meningiomas with pial feeders were included in the study. We set 5 mm diameter round Region Of Interests as many as possible within the tumor at the border with the brain parenchyma, and calculated the intratumoral CBV from pial supply. The reduction rate was defined as primary outcome, termed Δ pial-nCBV. Additionally, we collected data on the injection behavior of the n-Butyl-Cyanoacrylate (n-BCA), including intratumoral embolization (IE) and feeder occlusion. We then analyzed the association between each variable and Δ pial-nCBV.ResultsThe median Δ pial-nCBV was 25%. The n-BCA was applied in 22 (88%) cases, of which nine (36%) cases were injected into pial feeders. The use of n-BCA ( = .037), treatment with pial feeders ( = .002), and IE in meningeal feeders ( = .049) were associated with an increase in Δ pial-nCBV.ConclusionWe proposed a practical indicator, pial-nCBV, and increasing Δ pial-nCBV was associated with treating pial feeder using n-BCA.
背景与目的
脑膜瘤通常有软膜供血,术前经动脉栓塞术(TAE)进行去血管化是有效的。然而,由于软膜供血的脑膜瘤难以量化,TAE对其疗效指标仍不明确。因此,我们提出了一种从软膜供血中获取的实用且定量的肿瘤内脑血容量(CBV),称为软膜-nCBV。本研究旨在使用软膜-nCBV确定TAE对软膜供血脑膜瘤的疗效指标。
材料与方法
2015年至2021年期间,25例因软膜供血的脑膜瘤接受术前TAE和灌注磁共振成像(MRI)的患者纳入本研究。我们在肿瘤与脑实质交界处的肿瘤内尽可能多地设置直径5毫米的圆形感兴趣区,并计算软膜供血的肿瘤内CBV。降低率定义为主要结局,称为Δ软膜-nCBV。此外,我们收集了氰基丙烯酸正丁酯(n-BCA)的注射行为数据,包括肿瘤内栓塞(IE)和供血动脉闭塞。然后分析每个变量与Δ软膜-nCBV之间的关联。
结果
Δ软膜-nCBV的中位数为25%。22例(88%)使用了n-BCA,其中9例(36%)注入软膜供血动脉。n-BCA的使用(P = 0.037)、软膜供血动脉治疗(P = 0.002)和脑膜供血动脉的IE(P = 0.049)与Δ软膜-nCBV增加相关。
结论
我们提出了一个实用指标软膜-nCBV,并且Δ软膜-nCBV增加与使用n-BCA治疗软膜供血动脉有关。